Recombinase efficiency increases allow Qi Biodesign to insert 20-30 kb (5 or 6 genes) at one time at one location across a variety of different crop genetics. In addition, a large team at Qi Biodesign ...

Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.

Could it also give us better tomatoes, a hybrid woolly mammoth-elephant that could help save Arctic forests, and perhaps even ...

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...

A vast search of natural diversity has led scientists at MIT's McGovern Institute and the Broad Institute of MIT and Harvard ...

Although plant cell-based bioproduction has advanced considerably during the past several years, certain elements remain largely unexplored.

Madison's top 10 research grants from the National Institutes of Health, for which Trump announced a big cut, five involve ...

A provider of agtech research services says it has raised new funding from a St. Louis-based venture capital firm that will ...

Additionally, Editas Medicine management will participate in the following upcoming investor conferences in March: To access the live webcasts of Editas Medicine’s presentations, please visit the ...

The plant-editing system uses mRNA to avoid the risk that foreign DNA could be left behind and create unwanted mutations Chinese scientists have developed a gene-editing system for plants that draws ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal ...